ArticlePLoS neglected tropical diseases2025
Verifying interruption of transmission or elimination of Schistosoma japonicum must consider schistosome infections in wild rodents.
Article in PLoS neglected tropical diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Following the exciting announcement that Anhui Province, one of the historically most heavily Schistosoma japonicum endemic regions in China, has been officially declared to have achieved the goal of province-wide transmission interruption of schistosomiasis, we raise two concerns that merit further consideration. Firstly, S. japonicum is zoonotic, and in China it is known that humans, livestock, and wild animals such as rodents are major reservoirs of infection. While S. japonicum infections both in humans and bovines have recently been reduced to zero prevalence, infection persists at moderate to high levels within rodents with, for example, prevalence's reported of up to 12.81% within Anhui Province over last 5 years. Therefore, surveillance of schistosome infections in wild animals, at least in rodents, must be included in the criteria of verifying transmission interruption or elimination in China. Secondly, regarding how the official procedure of verification of transmission of interruption was assessed, we propose that a more accurate survey design and foci selection would be based, at least in part, upon areas where schistosome infections in either humans, domestic/wild animals and/or snails have recently been documented. This is particularly urgent, not only in terms of the long-term sustainability of disease control in China, but because many other countries are now fully acknowledging the zoonotic potential of schistosomiasis and are/or will soon enter this final elimination phase as officially outlined in the WHO's 2021-2030 Neglected Tropical Diseases Roadmap.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.